4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-005504
Options or other derivatives
- Director acquired 15,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hata Yujiro S Director | 2025-03-13 | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | D | ||
Loading xslF345X05/form4.xml…